CHEK2, which is associated with an intermediate risk for breast cancer and several other cancers [10], codes for a protein kinase that is downstream of the ATM and MRN complex in the DNA damage signaling cascade and transduces signals in response to DNA damage to regulators of apoptosis and the cell cycle. This evidence concerns the gene ATM and breast carcinoma.